News
Gilead will donate 1.5M doses of experimental coronavirus drug...
Gilead Sciences said it is donating 1.5 million doses of its experimental anti-coronavirus drug remdesivir, which could potentially treat 140,000 severely ill patients.
The doses are...
News
BiologIC’s pioneering digital hardware architectures for synthetic biology accelerated...
BiologIC Technologies, a pioneer in powerful digital architectures for radically disruptive automation hardware in synthetic biology, has announced today that it is accelerating development using...
News
PBOA Members Support Efforts Against COVID-19
The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports...
News
Mount Sinai Uses Remote Patient Monitoring to Rapidly Respond...
Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home. With the platform, providers can monitor...
News
GSK allies with Innovax for COVID-19 vaccine R&D project
GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel coronavirus behind the COVID-19 pandemic. The agreement gives Innovax access...
Clinical Trials
Ergomed Announces Provision of Clinical Research Services for Second...
Ergomed plc , a company focused on providing specialised services to the pharmaceutical industry, announces it is providing support for a clinical development programme for...
News
Gilead ramps up production of experimental Covid-19 treatment amid...
Gilead Sciences has been ramping up production of its experimental remdesivir treatment that is being tested to combat the novel coronavirus.
The drug maker now has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.